Assetmark, Inc Catalent, Inc. Transaction History

Assetmark, Inc

$32.1 Billion
Q2 2024

A detailed history of Assetmark, Inc transactions in Catalent, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 66 shares of CTLT stock, worth $3,981. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 8 725.0%

Holding current value

$3,981

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$53.58 - $57.02 $3,107 - $3,307	58 Added 725.0%	66 $3,000
Q1 2024 May 06, 2024	SELL	$42.56 - $59.82 $5,788 - $8,135	-136 Reduced 94.44%	8 $0
Q4 2023 Feb 09, 2024	BUY	$32.18 - $46.57 $4,633 - $6,706	144 New	144 $6,000
Q1 2023 May 05, 2023	BUY	$45.44 - $74.26 $366,564 - $599,055	8,067 Added 73336.36%	8,078 $530,000
Q4 2022 Feb 10, 2023	SELL	$41.39 - $81.0 $294,324 - $575,991	-7,111 Reduced 99.85%	11 $0
Q3 2022 Nov 01, 2022	BUY	$72.36 - $113.1 $47,034 - $73,515	650 Added 10.04%	7,122 $515,000
Q2 2022 Aug 03, 2022	BUY	$87.2 - $114.05 $83,624 - $109,373	959 Added 17.4%	6,472 $694,000
Q1 2022 May 13, 2022	BUY	$94.19 - $124.49 $259,305 - $342,720	2,753 Added 99.75%	5,513 $611,000
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $299,044 - $347,814	2,501 Added 965.64%	2,760 $353,000
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $28,275 - $36,868	259 New	259 $34,000
Q3 2020 Nov 13, 2020	SELL	$72.74 - $92.5 $38,988 - $49,580	-536 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$48.02 - $79.04 $27,899 - $45,922	-581 Reduced 52.01%	536 $39,000
Q1 2020 May 12, 2020	SELL	$36.95 - $62.95 $10,087 - $17,185	-273 Reduced 19.64%	1,117 $58,000
Q1 2019 May 14, 2019	SELL	$29.84 - $43.92 $1,432 - $2,108	-48 Reduced 3.34%	1,390 $56,000
Q4 2018 Feb 13, 2019	SELL	$29.95 - $46.34 $9,254 - $14,319	-309 Reduced 17.69%	1,438 $45,000
Q3 2018 Nov 13, 2018	SELL	$40.12 - $45.55 $361 - $409	-9 Reduced 0.51%	1,747 $80,000
Q2 2018 Aug 01, 2018	BUY	$38.72 - $42.52 $2,129 - $2,338	55 Added 3.23%	1,756 $74,000
Q1 2018 May 16, 2018	BUY	$39.4 - $47.39 $16,035 - $19,287	407 Added 31.45%	1,701 $70,000
Q4 2017 Feb 13, 2018	SELL	$37.27 - $43.02 $1,714 - $1,978	-46 Reduced 3.43%	1,294 $53,000
Q3 2017 Nov 08, 2017	BUY	$33.75 - $41.67 $3,273 - $4,041	97 Added 7.8%	1,340 $53,000
Q1 2017 Sep 15, 2017	BUY	N/A	4 Added 0.32%	1,243 $35,000
Q4 2016 Sep 15, 2017	SELL	N/A	-49 Reduced 3.8%	1,239 $33,000
Q3 2016 Sep 15, 2017	BUY	N/A	3 Added 0.23%	1,288 $33,000
Q1 2016 Sep 15, 2017	BUY	N/A	22 Added 1.74%	1,285 $34,000
Q4 2015 Sep 15, 2017	BUY	N/A	1,263	1,263 $32,000

Others Institutions Holding CTLT

# of Institutions

489

Shares Held

165M

Call Options Held

364K

Put Options Held

837K

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account